| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 01/20/2005 | US20050014686 Somatostatin analogues |
| 01/20/2005 | US20050014207 Monoclonal antibody hPAM4 |
| 01/20/2005 | US20050014167 Anterior gradient 2 homolog (AGR2) for use as to in identifying modulator for treatment of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, vision defects, inflammatory bowel and cell proliferative disorders |
| 01/20/2005 | US20050013778 Detecting localization of labeled annexin or fragment |
| 01/20/2005 | US20050013777 Method for detecting at least one substance in a metabolic process of a living being and device for carrying out the method |
| 01/20/2005 | US20050013775 Stability; intermetallic covalently linked to biological vector molecule; delivering radiolabel in tumor treatment or diagnosis |
| 01/20/2005 | CA2531118A1 Multivalent carriers of bi-specific antibodies |
| 01/19/2005 | EP1497445A2 Antibodies that specifically bind to gmad |
| 01/19/2005 | EP1496946A1 Method for obtaining a 2-18f-fluor-2-deoxy-d-glucose (18f-fdg)-solution |
| 01/19/2005 | EP1416963A4 Treating, preventing, or detecting angiogenesis with an anti-a2b antibody |
| 01/19/2005 | EP1027365B1 Antitumour uridine analogues |
| 01/19/2005 | CN1568198A Use of cd23 antagonists for the treatment of neoplastic disorders |
| 01/19/2005 | CN1185252C Somatostatin peptides |
| 01/19/2005 | CN1185210C Use of naphthalene-carboxylic acid for preparing a medicament used for treating diseases characterized by amyloid aggregation sedimentation |
| 01/18/2005 | US6844438 Therapy for drug abruse; side effect reduction |
| 01/18/2005 | US6844425 Combination of intercalating organometallic complexes and tumor seeking biomolecules for DNA cleavage and radiotherapy |
| 01/18/2005 | US6844319 Targeting Hepatic Stellate Cells (HSC) involved in sclerotic and/or fibrotic diseases with carrier linked to amino acid sequence SRNLIDC |
| 01/18/2005 | US6844153 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 01/18/2005 | US6843980 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 01/18/2005 | US6843979 Radiolabeled compounds useful as imaging agents for visualizing the location and density of serotonin transporter by tomography imaging; as diagnostic and therapeutic agents for diseases associated with serotonin transporter dysfunction |
| 01/18/2005 | CA2144043C Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/13/2005 | WO2005002629A1 Combination therapy of oxaliplatin and radioactively doped particles treating cancer |
| 01/13/2005 | US20050010038 Chelants and macrocyclic metal complex radiopharmaceuticals thereof |
| 01/13/2005 | US20050009865 Quinoline derivative as diagnostic probe for disease with tau protein accumulation |
| 01/13/2005 | US20050008575 Chelants and macrocyclic metal complex radiopharmaceuticals thereof |
| 01/13/2005 | US20050008572 Biocompatibility; sustained release |
| 01/13/2005 | US20050008568 Complex containing dithiocarbamate compound |
| 01/13/2005 | US20050008553 Using cation exchange resin; fluid flow of mixture of mother radionuclide and complexing agents; emission alpha particles |
| 01/12/2005 | EP1495031A1 Labeled oxazinocarbazoles as diagnostic agents |
| 01/12/2005 | EP1494709A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/12/2005 | EP1494700A2 Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents |
| 01/12/2005 | CN1564678A Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 01/12/2005 | CN1562971A Radioactive rhenium-N-accessory ingredient of alkyl dinitrogen disulfide for curing liver cancer and preparation method |
| 01/12/2005 | CN1184225C Tetraphosphine quatorphosphonium salt, its preparing process, and two-step tetraphosphine medicine kit and its application |
| 01/06/2005 | WO2005002293A2 Cox-2-targeted imaging agents |
| 01/06/2005 | WO2005001415A2 Optically pure and enriched isomers of chelating ligands and contrast agents |
| 01/06/2005 | WO2005000362A1 Tritiated growth hormone secretagogue mk-0677 |
| 01/06/2005 | WO2005000250A2 Imaging agents and methods of imaging alpha 7-nicotinic cholinergic receptor |
| 01/06/2005 | WO2004096138A3 [18f]-furanosylpurine derivatives and uses thereof |
| 01/06/2005 | WO2004094650A3 Synthesis of labeled metabolites |
| 01/06/2005 | WO2004082722A3 Radiolabeled conjugates based on substance p and the uses thereof |
| 01/06/2005 | US20050004010 Complex with antitumor agents; therapy, diagnosis |
| 01/06/2005 | US20050003466 Mimetic amino acid sequences for use in prevention and treatment of cell proliferative disorders |
| 01/06/2005 | US20050002945 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 01/06/2005 | US20050002942 Vitamin receptor binding drug delivery conjugates |
| 01/06/2005 | US20050002940 Cancerous disease modifying antibodies |
| 01/06/2005 | US20050002865 Diagnostic/therapeutic agents |
| 01/06/2005 | US20050002861 Technetium isotope; accumulating in situ site of pathology; radiolabeled peptide |
| 01/06/2005 | US20050002860 Compositions comprising a tissue glue and therapeutic agents |
| 01/06/2005 | US20050002859 COX-2-targeted imaging agents |
| 01/06/2005 | CA2530408A1 Cox-2-targeted imaging agents |
| 01/06/2005 | CA2529844A1 Tritiated growth hormone secretagogue mk-0677 |
| 01/06/2005 | CA2526760A1 Optically pure and enriched isomers of chelating ligands and contrast agents |
| 01/05/2005 | EP1493744A1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/05/2005 | EP1492776A2 Iodinated triglyceride analogs |
| 01/05/2005 | EP1492571A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 01/05/2005 | EP1492570A2 Method of diagnosis and treatment of breast lesions |
| 01/05/2005 | EP1492452A2 System, formulation, kit and method for tagging colonic residue in an individual |
| 01/05/2005 | EP0996619B1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/05/2005 | DE10324365A1 Vorrichtung mit einer Räumlichkeit zur Aufnahme von hyperpolarisiertem Edelgas Device with a space for receiving hyperpolarized noble gas |
| 01/05/2005 | CN1182876C Methods for detecting lesions in dense tissue using LHRH antagonists |
| 01/04/2005 | US6838291 For identifying compounds that bind to ion channel and may have antiarrhythmic activity |
| 01/04/2005 | US6838073 Cobalamin conjugates useful as imaging and therapeutic agents |
| 01/04/2005 | CA2285023C High avidity polyvalent and polyspecific reagents |
| 12/30/2004 | US20040266665 Therapy for thyroid disease; anticancer agents; metabolitic and reproductive diseases |
| 12/30/2004 | US20040265972 Modified human chorionic gonadotropin (CG) for use in treatment and prevention of metabolic and reproductive diseases |
| 12/30/2004 | US20040265824 Secreted and cell surface genes expressed in benign and malignant colorectal tumors |
| 12/30/2004 | US20040265392 Nanoparticles comprising biologically active tnf which is immobilized on the same |
| 12/30/2004 | US20040265241 Methods for the inhalation administration of antibiotics |
| 12/30/2004 | US20040265236 Trimeric macrocyclic substituted benzene derivatives |
| 12/30/2004 | US20040265232 [18F]-furanosylpurine derivatives and uses thereof |
| 12/30/2004 | US20040265231 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity |
| 12/30/2004 | US20040265230 Compositions and methods for diagnosing and treating colon cancers |
| 12/30/2004 | US20040265228 biomarkers for medicinal radioimaging such as Positron Emission Tomography; 4-Anilinoquinazolines |
| 12/30/2004 | US20040262158 Solid-state beta detector for microfluidic devices |
| 12/30/2004 | DE10344101B3 Producing carrier-free arsenic-72, e.g. useful for positron emission tomography, comprises irradiating target to produce selenium-72 and generating arsenic-72 by radioactive decay |
| 12/30/2004 | DE10325752A1 Lektin-Konjugate Lectin conjugates |
| 12/29/2004 | WO2004100769A3 Methods for using gadolinium as a contrast media |
| 12/29/2004 | WO2004096293A3 Method and device for radiotherapy |
| 12/29/2004 | EP1490114A1 Pendant fatty acid imaging agents |
| 12/29/2004 | EP1490111A2 Edg-receptor agonists for the treatment of hypertension |
| 12/29/2004 | EP1490110A2 Anti-alpha v beta 6 antibodies |
| 12/29/2004 | EP1028757B1 Radioactive embolizing compositions |
| 12/28/2004 | US6835549 Immunoassay method for the diagnosis of gastric intestinal metaplasia associated with gastric carcinoma |
| 12/28/2004 | US6835370 Diagnosis and treatment of malignant neoplasms |
| 12/23/2004 | WO2004110963A2 Glycerophosphocholine and its derivatives for medical imaging neuropsychiatric disorders |
| 12/23/2004 | WO2004110500A1 Radioactively labelled amino acid analogues, their preparation and use |
| 12/23/2004 | WO2004110390A2 Anti-cd74 immunoconjugates and methods |
| 12/23/2004 | WO2004110339A2 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 12/23/2004 | WO2004110151A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments |
| 12/23/2004 | WO2004078914A3 A fluorinase enzyme and use thereof in fluorination synthesis |
| 12/23/2004 | WO2003083436A3 Fibrinogen binding moieties |
| 12/23/2004 | US20040260143 Delivery methods, systems and components for use with hazardous pharmaceutical substances |
| 12/23/2004 | US20040260073 Methods for purifying radiolabelled compounds |
| 12/23/2004 | US20040258744 Surface modified lipoprotein-like oil in water emulsion having lipophilic core surrounded by monolayer of amphiphilic or polar lipids; polyoxyethylene glycol linked lipid and (choles)terol; radioactive or stable, synthetic polyhalogenated triglycerides as contrast agents; radiographic imaging |
| 12/23/2004 | US20040258693 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics to deposit PTA-4890 at the ATCC |
| 12/23/2004 | US20040258620 In vivo stability, biocompatibility, organ specificity; low dosage, rapid excretion; nuclear magnetic resonance diagnostic imaging, radiotherapy |
| 12/23/2004 | US20040258619 Diaminedioxime radiometal complexes |
| 12/23/2004 | US20040258616 Compositions and methods for treating cancer using IGSF9 and LIV-1 |
| 12/23/2004 | US20040258615 Microfluidic coupling of radioactive isotope to reactive precursor; positron emission tomography; 2-deoxy-2-[18F] fluoro-D-glucose (FDG) |